New Apps Supporting Biologics Registration, Inventory and High Throughput Screening (HTS) Added to Platform for Science Marketplace
BRANFORD, Connecticut, March 7, 2016 /PRNewswire/ -- Core Informatics today announced the availability of a suite of new applications for therapeutic biologics discovery and development. The apps provide ready-to-go capabilities for scientists and researchers to seamlessly execute biologic sample registration and HTS workflows, while tracking and managing sample data and lineage across experiments, containers and locations. The apps include configurable dashboards to provide lab teams and business leaders with immediate visibility into project status and key metrics to enhance decision making.
Logo - http://photos.prnewswire.com/prnh/20150615/223236LOGO
"We use Core's platform to support our structural and functional biology efforts as part of our Integrated Lead Discovery Platform," said Art Morales, Vice President, Technology and Corporate Development at Beryllium. "Our scientists use Core LIMS to enable our complex biologics workflows, and collect and analyze our data rapidly and accurately. We are excited about the expansion of the biologics apps suite in Core's Platform for Science Marketplace, continuing their commitment to provide innovative informatics solutions for drug discovery."
The combination of biologics registration, biochemical and cell-based HTS, and sample inventory applications, provides traceability across drug discovery workflows. Customers can add new sample types and relationships, container types, and other entities through configuration in a few clicks, making new data structures available to scientists in the lab immediately and without requiring any custom code. Customers can leverage the sequence tracking capabilities provided by these apps, which ensure registration integrity, provide calculated properties and support customer-defined dictionaries to distinguish modified nucleic and amino acid residues. The apps can be used individually to support a portion of a larger biologics workflow, or linked together to provide an enterprise-level platform to support all of an organization's biologics activities.
The new apps are built on Core Informatics' Platform for Science (PFS), enabling customers to add on to their existing PFS deployment over time. By using PFS apps, customers also benefit from Core Informatics' robust RESTful APIs (Application Programming Interfaces), instrument integrations (Core SDMS), and collaboration tools and functionalities (Core Collaboration and Core ELN). The biologics apps are available through Core Informatics' Platform for Science Marketplace.
"We have seen strong demand from the leading biopharmaceutical companies for our comprehensive informatics solution supporting therapeutic biologics discovery," said Anthony Uzzo, President and Co-Founder of Core Informatics. "These new apps represent industry best-practices for biologics data management and are built to meet the needs of cutting-edge biopharma organizations by providing them with the ability to define, collect, and securely share diverse data within a single platform. We are excited about expanding the Platform for Science Marketplace, and providing these ready-to-go biologics capabilities."
About Core Informatics
Core Informatics provides innovative data management software to accelerate scientific discovery, research, development and collaboration. Core Informatics' Scientific Platform-as-a-Service (sPaaS) includes web-based LIMS, ELN, SDMS and Collaboration products and applications, all built on the Platform for Science, that help scientists decrease complexity and increase efficiency while automating laboratory workflows and facilitating collaborations to derive more value and insight from their data. With dozens of major companies and thousands of scientists already using its software, Core Informatics has received recognition from industry analysts and publications as a transformational leader in the industry. Founded in 2006, Core Informatics supports customers worldwide from its offices in Branford, CT; Cambridge, MA; San Diego, CA and London, England.
Share this article